Comments: NY S08991 | 2023-2024 | General Assembly

Bill Title: Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

Spectrum: Bipartisan Bill

Status: (Introduced) 2024-06-03 - PRINT NUMBER 8991A [S08991 Detail]

Text: Latest bill text (Amended) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 New York S08991 at this time.

Social Comments on NY S08991

feedback